New insights regarding HCV-NS5A structure/function and indication of genotypic differences
<p>Abstract</p> <p>Background</p> <p>HCV is prevalent throughout the world. It is a major cause of chronic liver disease. There is no effective vaccine and the most common therapy, based on Peginterferon, has a success rate of ~50%. The mechanisms underlying viral resis...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-01-01
|
Series: | Virology Journal |
Subjects: | |
Online Access: | http://www.virologyj.com/content/9/1/14 |